U.S. Markets open in 15 hrs, 10 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 6.03 03:07 PM EST | |
|---|---|---|
| Day High | 6.37 10:13 AM EST |
|
| Range | 0.34 |
| Volume | 189,766 | |
|---|---|---|
| 30-Day Avg Vol | 364,000 |
|
| Difference | -47.87% |
| Market Cap | 548.20 M | |
|---|---|---|
| Mkt Cap Chg | -10.76 M |
| Shares Out | 89.72 M | |
|---|---|---|
| % Shrs Traded | 0.21% | |
| 1yr EPS Est | -0.611 |
| 52-Wk Low | 2.60 | |
|---|---|---|
| 52-Wk High | 8.09 |
|
| Range | 5.49 |
| Prev Close | 6.23 11/5/09 | |
|---|---|---|
| Today's Open | 6.18 | |
| Change | -0.80% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.15 M |
| Revenue (LFY) | 8.76 M | |
|---|---|---|
| Earnings (LFY) | -48.65 M | |
| Earnings (MRQ) | -17.06 M | |
| Next Earn Est | -0.178 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.72 | |
| 1yr EPS Growth | 19.61% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -10.00 | |
| PEG Ratio | — | |
| Return on Equity | -131.17 | |
| Beta | 1.57 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Halozyme Therapeutics makes enzymes for therapeutic and drug delivery applications. The company's products are based on recombinant human PH20, a human synthetic enzyme it hopes will offer safety benefits ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.178 11/6/09 | — — |
—
—
|
| Last Quarter | -0.178 9/30/09 | -0.16 9/30/09 |
0.018
Beat
|
| 2 Quarters Ago | -0.167 6/30/09 | -0.21 6/30/09 |
-0.043
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 1.43 M | 8.76 M |
| Gross Profit | 1.03 M | -35.80 M |
| Operating Income | -17.08 M | -49.80 M |
| Net Income | -17.06 M | -48.65 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts